|
Name |
Tetrakis(trimethylsiloxy)silane
|
Molecular Formula | C12H36O4Si5 | |
IUPAC Name* |
tetrakis(trimethylsilyl) silicate
|
|
SMILES |
C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C
|
|
InChI |
InChI=1S/C12H36O4Si5/c1-17(2,3)13-21(14-18(4,5)6,15-19(7,8)9)16-20(10,11)12/h1-12H3
|
|
InChIKey |
VNRWTCZXQWOWIG-UHFFFAOYSA-N
|
|
Synonyms |
3555-47-3; TETRAKIS(TRIMETHYLSILOXY)SILANE; Tetrakis(trimethylsilyl) orthosilicate; tetrakis(trimethylsilyl) silicate; Tetrakis(trimethylsilyloxy)silane; Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis(trimethylsiloxy)-; 55L9T9A11I; Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis((trimethylsilyl)oxy)-; Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]-; UNII-55L9T9A11I; TETRATRIMETHYLSILYL SILICATE; EINECS 222-613-4; SCHEMBL28013; DTXSID9042463; Tetrakis(trimethylsilyl)orthosilicate; MFCD00051587; AKOS025295217; ZINC169746866; FS-5542; Tetrakis(trimethylsilyloxy)silane, 97%; Tetrakis(trimethylsilyl) orthosilicate #; CS-0187690; T3494; D92706; SILICIC ACID, TETRAKIS(TRIMETHYLSILYL) ESTER; Q27261316; 1,1,5,5,5-Hexamethyl-3,3-bis((trimethylsilyl)oxy)trisiloxane; SILICIC ACID (H4SIO4), TETRAKIS(TRIMETHYLSILYL) ESTER; 1,1,1,5,5,5-hexamethyl-3,3-bis-(trimethylsilanyloxy)-trisiloxane; SILANOL, TRIMETHYL-, TETRAESTER WITH SILICIC ACID (H4SIO4)
|
|
CAS | 3555-47-3 | |
PubChem CID | 19086 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.84 | ALogp: | 4.8 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 36.9 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.537 |
Caco-2 Permeability: | -5.964 | MDCK Permeability: | 0.00016661 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.061 |
Human Intestinal Absorption (HIA): | 0.965 | 20% Bioavailability (F20%): | 0.477 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 100.97% |
Volume Distribution (VD): | 3.691 | Fu: | 46.82% |
CYP1A2-inhibitor: | 0.592 | CYP1A2-substrate: | 0.98 |
CYP2C19-inhibitor: | 0.628 | CYP2C19-substrate: | 0.955 |
CYP2C9-inhibitor: | 0.477 | CYP2C9-substrate: | 0.895 |
CYP2D6-inhibitor: | 0.122 | CYP2D6-substrate: | 0.881 |
CYP3A4-inhibitor: | 0.078 | CYP3A4-substrate: | 0.113 |
Clearance (CL): | 3.37 | Half-life (T1/2): | 0.411 |
hERG Blockers: | 0.345 | Human Hepatotoxicity (H-HT): | 0.004 |
Drug-inuced Liver Injury (DILI): | 0.007 | AMES Toxicity: | 0.029 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.549 |
Skin Sensitization: | 0.942 | Carcinogencity: | 0.075 |
Eye Corrosion: | 1 | Eye Irritation: | 0.997 |
Respiratory Toxicity: | 0.401 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001271 | 0.646 | D0H2DQ | 0.094 | ||||
ENC000373 | 0.506 | D0Z1ZM | 0.094 | ||||
ENC001784 | 0.422 | D0L2UN | 0.090 | ||||
ENC001783 | 0.407 | D02YIZ | 0.089 | ||||
ENC001785 | 0.403 | D04JMQ | 0.088 | ||||
ENC001404 | 0.370 | D03HJK | 0.087 | ||||
ENC001122 | 0.346 | D06IGU | 0.086 | ||||
ENC001182 | 0.333 | D0K3LW | 0.086 | ||||
ENC001123 | 0.325 | D05SJW | 0.085 | ||||
ENC001149 | 0.325 | D06ZUP | 0.084 |